Schonfeld Strategic Advisors LLC Vir Biotechnology, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 275,761 shares of VIR stock, worth $2.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
275,761
Previous 22,366
1132.95%
Holding current value
$2.1 Million
Previous $226,000
985.84%
% of portfolio
0.02%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VIR
# of Institutions
228Shares Held
87.5MCall Options Held
231KPut Options Held
132K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$127 Million1.37% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$125 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$97.9 Million0.0% of portfolio
-
State Street Corp Boston, MA5.09MShares$38.8 Million0.0% of portfolio
-
Baillie Gifford & CO3.92MShares$29.9 Million0.03% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.01B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...